These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19430097)

  • 1. Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1.
    Maneewatch S; Thanongsaksrikul J; Songserm T; Thueng-In K; Kulkeaw K; Thathaisong U; Srimanote P; Tongtawe P; Tapchaisri P; Chaicumpa W
    Antivir Ther; 2009; 14(2):221-30. PubMed ID: 19430097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.
    Prabhu N; Prabakaran M; Hongliang Q; He F; Ho HT; Qiang J; Goutama M; Lim AP; Hanson BJ; Kwang J
    Antivir Ther; 2009; 14(7):911-21. PubMed ID: 19918095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fab MAbs specific to HA of influenza virus with H5N1 neutralizing activity selected from immunized chicken phage library.
    Pitaksajjakul P; Lekcharoensuk P; Upragarin N; Barbas CF; Ibrahim MS; Ikuta K; Ramasoota P
    Biochem Biophys Res Commun; 2010 May; 395(4):496-501. PubMed ID: 20382115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
    Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
    Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human single chain monoclonal antibody that recognizes matrix protein of heterologous influenza A virus subtypes.
    Poungpair O; Chaicumpa W; Kulkeaw K; Maneewatch S; Thueng-in K; Srimanote P; Tongtawe P; Songserm T; Lekcharoensuk P; Tapchaisri P
    J Virol Methods; 2009 Jul; 159(1):105-11. PubMed ID: 19442853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.
    Lim AP; Chan CE; Wong SK; Chan AH; Ooi EE; Hanson BJ
    Virol J; 2008 Oct; 5():130. PubMed ID: 18957074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.
    Kreijtz JH; Suezer Y; de Mutsert G; van den Brand JM; van Amerongen G; Schnierle BS; Kuiken T; Fouchier RA; Löwer J; Osterhaus AD; Sutter G; Rimmelzwaan GF
    Vaccine; 2009 Oct; 27(45):6296-9. PubMed ID: 19840663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generating and characterizing monoclonal and polyclonal antibodies against avian H5N1 hemagglutinin protein.
    Wang SF; Chen KH; Thitithanyanont A; Yao L; Lee YM; Chan YJ; Liu SJ; Chong P; Liu WT; Huang JC; Chen YM
    Biochem Biophys Res Commun; 2009 May; 382(4):691-6. PubMed ID: 19327345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
    Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.
    Patel A; Tran K; Gray M; Li Y; Ao Z; Yao X; Kobasa D; Kobinger GP
    Vaccine; 2009 May; 27(23):3083-9. PubMed ID: 19428922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes.
    Chen Y; Qin K; Wu WL; Li G; Zhang J; Du H; Ng MH; Shih JW; Peiris JS; Guan Y; Chen H; Xia N
    J Infect Dis; 2009 Jan; 199(1):49-58. PubMed ID: 19032063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.
    Kreijtz JH; Suezer Y; de Mutsert G; van den Brand JM; van Amerongen G; Schnierle BS; Kuiken T; Fouchier RA; Löwer J; Osterhaus AD; Sutter G; Rimmelzwaan GF
    J Infect Dis; 2009 Feb; 199(3):405-13. PubMed ID: 19061423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology. Flu antibodies stir new hope for treatment, vaccine.
    Leslie M
    Science; 2009 Feb; 323(5918):1160. PubMed ID: 19251602
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein.
    Wang R; Song A; Levin J; Dennis D; Zhang NJ; Yoshida H; Koriazova L; Madura L; Shapiro L; Matsumoto A; Yoshida H; Mikayama T; Kubo RT; Sarawar S; Cheroutre H; Kato S
    Antiviral Res; 2008 Nov; 80(2):168-77. PubMed ID: 18598723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific polyclonal F(ab')2 neutralize a large panel of highly pathogenic avian influenza A viruses (H5N1) and control infection in mice.
    Herbreteau CH; Jacquot F; Rith S; Vacher L; Nguyen L; Carbonnelle C; Lotteau V; Jolivet M; Raoul H; Buchy P; Saluzzo JF
    Immunotherapy; 2014; 6(6):699-708. PubMed ID: 24673720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on preparation and identification of monoclonal antibodies immunized with H5N1 influenza virus M1 protein].
    Chen AJ; Yao LH; Guo JQ; Xu Y; Liu XY; Jia RQ; Zhang ZQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):412-4. PubMed ID: 20718341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human monoclonal ScFv that bind to different functional domains of M2 and inhibit H5N1 influenza virus replication.
    Pissawong T; Maneewatch S; Thueng-In K; Srimanote P; Dong-din-on F; Thanongsaksrikul J; Songserm T; Tongtawe P; Bangphoomi K; Chaicumpa W
    Virol J; 2013 May; 10():148. PubMed ID: 23672256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human 4F5 single-chain Fv antibody recognizing a conserved HA1 epitope has broad neutralizing potency against H5N1 influenza A viruses of different clades.
    Zhang X; Qi X; Zhang Q; Zeng X; Shi Z; Jin Q; Zhan F; Xu Y; Liu Z; Feng Z; Jiao Y
    Antiviral Res; 2013 Aug; 99(2):91-9. PubMed ID: 23680121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of Influenza virus infection in formalin-fixed tissues with anti-H5 monoclonal antibody recognizing FFWTILKP.
    He F; Du Q; Ho Y; Kwang J
    J Virol Methods; 2009 Jan; 155(1):25-33. PubMed ID: 18930768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.